Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study

NCT02736344 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.

NCT NCT02736344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study
Lead sponsor
Medinol Ltd.
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
September 30, 2021
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease